Matthew Kurian, Executive Committee Member at KYSCO, shared on LinkedIn:
“Great to participate in this Beyond the Headlines discussion from i3 Health, Oncology Data Advisors with rising and upcoming junior faculty at Winship Cancer Institute of Emory University, Jasmin Hundal, on where we believe AI is actually headed specifically within breast oncology:
From screening and diagnostics to clinical decision support and how we can thoughtfully integrate these tools into everyday care.
AI will continue to change what we do– but the most exciting part is seeing the next generation of oncologists help shape how we can use it better.
You can also read:
Discussions Around the FDA Approval of Camizestrant Based on the SERENA-6 Trial
